These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 8299434)
21. Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009. de Beaufort CE; Lange K; Swift PG; Aman J; Cameron F; Castano L; Dorchy H; Fisher LK; Hoey H; Kaprio E; Kocova M; Neu A; Njolstad PR; Phillip M; Schoenle E; Robert JJ; Urukami T; Vanelli M; Danne T; Barrett T; Chiarelli F; Aanstoot HJ; Mortensen HB; Pediatr Diabetes; 2013 Sep; 14(6):422-8. PubMed ID: 22957743 [TBL] [Abstract][Full Text] [Related]
22. Persistent C-peptide is associated with reduced hypoglycaemia but not HbA Marren SM; Hammersley S; McDonald TJ; Shields BM; Knight BA; Hill A; Bolt R; Tree TI; Roep BO; Hattersley AT; Jones AG; Oram RA; Diabet Med; 2019 Sep; 36(9):1092-1099. PubMed ID: 30955221 [TBL] [Abstract][Full Text] [Related]
23. Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels. Rama Chandran S; A Vigersky R; Thomas A; Lim LL; Ratnasingam J; Tan A; S L Gardner D Diabetes Technol Ther; 2020 Feb; 22(2):103-111. PubMed ID: 31502876 [No Abstract] [Full Text] [Related]
24. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group. Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395 [TBL] [Abstract][Full Text] [Related]
25. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes. Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502 [TBL] [Abstract][Full Text] [Related]
26. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Fanelli CG; Epifano L; Rambotti AM; Pampanelli S; Di Vincenzo A; Modarelli F; Lepore M; Annibale B; Ciofetta M; Bottini P Diabetes; 1993 Nov; 42(11):1683-9. PubMed ID: 8405713 [TBL] [Abstract][Full Text] [Related]
27. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study. Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson WG; Levin S; Nuttall F; Sawin C; Silbert C; Lee HS; Johnson-Nagel N Diabetes Care; 1996 Dec; 19(12):1375-81. PubMed ID: 8941467 [TBL] [Abstract][Full Text] [Related]
28. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study. Gubitosi-Klug RA; Braffett BH; White NH; Sherwin RS; Service FJ; Lachin JM; Tamborlane WV; Diabetes Care; 2017 Aug; 40(8):1010-1016. PubMed ID: 28550194 [TBL] [Abstract][Full Text] [Related]
29. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846 [TBL] [Abstract][Full Text] [Related]
30. A low-glycemic index meal and bedtime snack prevents postprandial hyperglycemia and associated rises in inflammatory markers, providing protection from early but not late nocturnal hypoglycemia following evening exercise in type 1 diabetes. Campbell MD; Walker M; Trenell MI; Stevenson EJ; Turner D; Bracken RM; Shaw JA; West DJ Diabetes Care; 2014 Jul; 37(7):1845-53. PubMed ID: 24784832 [TBL] [Abstract][Full Text] [Related]
31. The Association Between HbA Seyed Ahmadi S; Westman K; Pivodic A; Ólafsdóttir AF; Dahlqvist S; Hirsch IB; Hellman J; Ekelund M; Heise T; Polonsky W; Wijkman M; Schwarcz E; Lind M Diabetes Care; 2020 Sep; 43(9):2017-2024. PubMed ID: 32641374 [TBL] [Abstract][Full Text] [Related]
32. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide. Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z; Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007 [TBL] [Abstract][Full Text] [Related]
33. Muscle sympathetic nerve activity is higher in intensively versus conventionally treated IDDM subjects. Hoffman RP; Sinkey CA; Anderson EA Diabetes Care; 1995 Mar; 18(3):287-91. PubMed ID: 7555469 [TBL] [Abstract][Full Text] [Related]
34. Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group. Diabetes Care; 1987; 10(1):1-19. PubMed ID: 2882967 [TBL] [Abstract][Full Text] [Related]
35. Voglibose administration before the evening meal improves nocturnal hypoglycemia in insulin-dependent diabetic patients with intensive insulin therapy. Taira M; Takasu N; Komiya I; Taira T; Tanaka H Metabolism; 2000 Apr; 49(4):440-3. PubMed ID: 10778865 [TBL] [Abstract][Full Text] [Related]
36. Split-mixed insulin regimen with human ultralente before supper and NPH (isophane) before breakfast in children and adolescents with IDDM. Wolfsdorf JI; Laffel LM; Pasquarello C; Vernon A; Herskowitz RD Diabetes Care; 1991 Nov; 14(11):1100-6. PubMed ID: 1797498 [TBL] [Abstract][Full Text] [Related]
37. Carbohydrate counting accuracy and blood glucose variability in adults with type 1 diabetes. Brazeau AS; Mircescu H; Desjardins K; Leroux C; Strychar I; Ekoé JM; Rabasa-Lhoret R Diabetes Res Clin Pract; 2013 Jan; 99(1):19-23. PubMed ID: 23146371 [TBL] [Abstract][Full Text] [Related]
38. Impact of bedtime snack composition on prevention of nocturnal hypoglycemia in adults with type 1 diabetes undergoing intensive insulin management using lispro insulin before meals: a randomized, placebo-controlled, crossover trial. Kalergis M; Schiffrin A; Gougeon R; Jones PJ; Yale JF Diabetes Care; 2003 Jan; 26(1):9-15. PubMed ID: 12502652 [TBL] [Abstract][Full Text] [Related]
39. Mediation of the association of smoking and microvascular complications by glycemic control in type 1 diabetes. Braffett BH; Rice MM; Young HA; Lachin JM PLoS One; 2019; 14(1):e0210367. PubMed ID: 30615671 [TBL] [Abstract][Full Text] [Related]
40. Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control. Soliman AT; Omar M; Assem HM; Nasr IS; Rizk MM; El Matary W; El Alaily RK Metabolism; 2002 Mar; 51(3):292-6. PubMed ID: 11887162 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]